Table 7 shows the direct or indirect regulatory effects of probiotics on circulating TMAO level
American Diabetes Association (ADA): "GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes and Beyond." ADA, Diabetes Care, 2018
Chronic exposure to mycotoxins is known to have a diverse and powerful impact on human health
Take tirzepatide first, where Willards pharmacology work in JCI Insight shows the molecule, LY3298176, turning on both the GIP and GLP-1 receptors
Also, n-3 lowers the increased caspase-3 and calpain activity detected by p-nitroanilin absorbance and calcium- and non-calcium-dependent fluorescence in ethanol conditions, reducing cell injury, neurodegeneration, brain hemorrhage, congestion, necrosis, leukocytosis and microglia activation (43)